Skinesa Information

Skinesa produces an evidence-based oral skin probiotic that targets eczema & psoriasis through the gut-skin connection. Our patented probiotic blend is the first and only to be published in JAMA Dermatology for research involving atopic dermatitis, demonstrating an 83% reduction in disease severity in a randomized, double-blind, placebo-controlled trial. With 150,000 successful transformations and over 1000 doctors already recommending our adult capsules and kids' chewables, we are continuing to expand our national footprint to help millions heal naturally. You can learn more at skinesa.com